Feligen CRP lyofilisaat en suspendeervloeistof voor suspensie voor injectie voor katten
Feligen CRP lyofilisaat en suspendeervloeistof voor suspensie voor injectie voor katten
Authorised
- Feline panleucopenia virus, strain LR 72, Live
- Feline rhinotracheitis virus, strain F2, Live
- Feline calicivirus, strain F9, Live
Product identification
Medicine name:
Feligen CRP lyofilisaat en suspendeervloeistof voor suspensie voor injectie voor katten
Active substance:
- Feline panleucopenia virus, strain LR 72, Live
- Feline rhinotracheitis virus, strain F2, Live
- Feline calicivirus, strain F9, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline panleucopenia virus, strain LR 72, Live5011.90/unit(s)1.00millilitre(s)
-
Feline rhinotracheitis virus, strain F2, Live100000.00/unit(s)1.00millilitre(s)
-
Feline calicivirus, strain F9, Live39810.70/unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 4521
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/02/2022
How useful was this page?:
